FDA Starts New Plan to Make Drug Trials Faster
The FDA begins a new program to speed up early drug trials, aiming to match the quick pace of other countries.
Drug research often moves slowly. This means new medicines take a long time to reach people who need them. The U.S. Food and Drug Administration (FDA) wants to change this. They just started a new pilot program.
This program helps make early drug tests, called Phase 1 trials, go faster. Companies can apply to get their new drug applications reviewed more quickly. The FDA hopes this new process will put U.S. trials on the same speed as those in China and Australia.
Speeding up these trials is important. It means new treatments for serious diseases could become available sooner. This helps patients and their families. This new plan shows the FDA wants to help more new drugs reach patients faster.
Source: FierceBiotech
More from Biotech
